Literature DB >> 11483632

High prevalence of low HDL cholesterol concentrations and mixed hyperlipidemia in a Mexican nationwide survey.

C A Aguilar-Salinas1, G Olaiz, V Valles, J M Torres, F J Gómez Pérez, J A Rull, R Rojas, A Franco, J Sepulveda.   

Abstract

The prevalence of lipid abnormalities revealed in a survey done in 417 Mexican cities is described. Information was obtained on 15,607 subjects, aged 20 to 69 years. In this report, only samples obtained after a 9- to 12-h fast were included (2,256 cases: 953 men and 1,303 women). The population is representative of Mexican urban adults. Mean lipid concentrations were: cholesterol, 4.80 mmol/l; triglycerides, 2.39 mmol/l; HDL cholesterol, 1.00 mmol/l; and LDL cholesterol, 3.06 mmol/l. The most prevalent abnormality was HDL cholesterol below 0.9 mmol/l (46.2% for men and 28.7% for women). Hypertriglyceridemia (>2.26 mmol/l) was the second most prevalent abnormality (24.3%). Severe hypertriglyceridemia (>11.2 mmol/l) was observed in 0.42% of the population. Increased LDL cholesterol (> or =4.21 mmol/l) was observed in 11.2% of the sample. Half of the hypertriglyceridemic subjects had a mixed dyslipidemia or low HDL cholesterol. More than 50% of the low HDL cholesterol cases were not related to hypertriglyceridemia. Insulin resistance was found in 59% of them. In conclusion, the prevalence of hypoalphalipoproteinemia and other forms of dyslipidemia in Mexican adults is very high and it is among the highest previously reported worldwide.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11483632

Source DB:  PubMed          Journal:  J Lipid Res        ISSN: 0022-2275            Impact factor:   5.922


  54 in total

Review 1.  Genetic and environmental determinants of the susceptibility of Amerindian derived populations for having hypertriglyceridemia.

Authors:  Carlos A Aguilar-Salinas; Teresa Tusie-Luna; Päivi Pajukanta
Journal:  Metabolism       Date:  2014-03-30       Impact factor: 8.694

2.  Non-culprit coronary lesions in young patients have higher rates of atherosclerotic progression.

Authors:  Jiantao Li; Yunfeng Han; Jing Jing; Shengxian Tu; Weiren Chen; Johan H C Reiber; Yundai Chen
Journal:  Int J Cardiovasc Imaging       Date:  2015-03-10       Impact factor: 2.357

3.  The N342S MYLIP polymorphism is associated with high total cholesterol and increased LDL receptor degradation in humans.

Authors:  Daphna Weissglas-Volkov; Anna C Calkin; Teresa Tusie-Luna; Janet S Sinsheimer; Noam Zelcer; Laura Riba; Ana Maria Vargas Tino; Maria Luisa Ordoñez-Sánchez; Ivette Cruz-Bautista; Carlos A Aguilar-Salinas; Peter Tontonoz; Päivi Pajukanta
Journal:  J Clin Invest       Date:  2011-07-18       Impact factor: 14.808

Review 4.  Plasma lipoprotein concentrations in ethnic populations.

Authors:  Karol E Watson
Journal:  Curr Cardiol Rep       Date:  2003-11       Impact factor: 2.931

5.  Insulin resistance and its association with the components of the metabolic syndrome among obese children and adolescents.

Authors:  Carlos Juárez-López; Miguel Klünder-Klünder; Patricia Medina-Bravo; Adrián Madrigal-Azcárate; Eliezer Mass-Díaz; Samuel Flores-Huerta
Journal:  BMC Public Health       Date:  2010-06-07       Impact factor: 3.295

Review 6.  Current status and future directions in lipid management: emphasizing low-density lipoproteins, high-density lipoproteins, and triglycerides as targets for therapy.

Authors:  Yun Lin; Shaymaa S Mousa; Nabil Elshourbagy; Shaker A Mousa
Journal:  Vasc Health Risk Manag       Date:  2010-03-03

7.  A systems genetics approach implicates USF1, FADS3, and other causal candidate genes for familial combined hyperlipidemia.

Authors:  Christopher L Plaisier; Steve Horvath; Adriana Huertas-Vazquez; Ivette Cruz-Bautista; Miguel F Herrera; Teresa Tusie-Luna; Carlos Aguilar-Salinas; Päivi Pajukanta
Journal:  PLoS Genet       Date:  2009-09-11       Impact factor: 5.917

Review 8.  Genomic medicine in gastroenterology: A new approach or a new specialty?

Authors:  Sonia Roman; Arturo Panduro
Journal:  World J Gastroenterol       Date:  2015-07-21       Impact factor: 5.742

9.  TCF7L2 is associated with high serum triacylglycerol and differentially expressed in adipose tissue in families with familial combined hyperlipidaemia.

Authors:  A Huertas-Vazquez; C Plaisier; D Weissglas-Volkov; J Sinsheimer; S Canizales-Quinteros; I Cruz-Bautista; E Nikkola; M Herrera-Hernandez; A Davila-Cervantes; T Tusie-Luna; M-R Taskinen; C Aguilar-Salinas; P Pajukanta
Journal:  Diabetologia       Date:  2007-10-31       Impact factor: 10.122

10.  Physical activity and risk of metabolic syndrome in an urban Mexican cohort.

Authors:  Pablo Méndez-Hernández; Yvonne Flores; Carole Siani; Michel Lamure; L Darina Dosamantes-Carrasco; Elizabeth Halley-Castillo; Gerardo Huitrón; Juan O Talavera; Katia Gallegos-Carrillo; Jorge Salmerón
Journal:  BMC Public Health       Date:  2009-07-31       Impact factor: 3.295

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.